A Study of RO5083945 in Combination With Chemotherapy Versus Chemotherapy Alone in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Phase II Trial of Pemetrexed-Based Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Previously Irradiated Head and Neck Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)
- Status
- COMPLETED
- Phase
- PHASE2
BI 6727 (Volasertib) Randomised Trial in Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Pemetrexed and Gemcitabine for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2